398119-27-2

Basic information

• Product Name: 3-BroMo-5-forMyl-benzoic acid
• Synonyms: 3-BroMo-5-forMyl-benzoic acid;5-Bromo-3-formylbenzoic acid;3-Formyl-5-bromobenzoic acid
• CAS NO: 398119-27-2
• Molecular Formula: C₈H₅BrO₃
• Molecular Weight: 229.0275
• EINECS: -0
• Mol File: 398119-27-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 377.9±32.0 °C(Predicted)
• Appearance: /
• Density: 1.764±0.06 g/cm3(Predicted)
• PKA: 3.46±0.10(Predicted)
• CAS DataBase Reference: 3-BroMo-5-forMyl-benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BroMo-5-forMyl-benzoic acid(398119-27-2)
• EPA Substance Registry System: 3-BroMo-5-forMyl-benzoic acid(398119-27-2)

Safety Data

• Hazardous Substances Data: 398119-27-2(Hazardous Substances Data)

Usage

General Description

3-Bromo-5-formyl-benzoic acid is a chemical compound that consists of a benzoic acid core with a bromine atom at the 3 position and a formyl group at the 5 position. It is commonly used as a building block in organic chemistry for the synthesis of various functionalized aromatic compounds. 3-BroMo-5-forMyl-benzoic acid has potential applications in the pharmaceutical and agrochemical industries due to its ability to serve as a precursor for the synthesis of novel biologically active molecules. Additionally, it is also used as a reagent in cross-coupling reactions and other transformations in organic synthesis. Overall, 3-Bromo-5-formyl-benzoic acid is a versatile chemical that is widely used in the field of organic chemistry for the preparation of various functionalized aromatic compounds.

Upstream product

• 377734-27-5 methyl 3-bromo-5-formylbenzoate 
• 619-21-6 m-formylphenyl benzoic acid 

Downstream Products

• 161796-10-7 3-bromo-5-(methoxycarbonyl)benzoic acid 
• 1186519-40-3 4'-methyl-N-((6-methylpyridin-3-yl)methyl)-5-(oxiran-2-yl)biphenyl-3-carboxamide 
• 1018948-99-6 t-butyl 5-bromo-3-carboxybenzoate 
• 1187028-43-8 3-formyl-5-isopropylbenzoic acid 
• 1187028-42-7 3-formyl-5-propylbenzoic acid 
• 1187028-41-6 5-ethyl-3-formylbenzoic acid 
• 1187029-44-2 (S)-N-(3-(2-ethyl-4-(5-(3-((isobutyl(methyl)amino)methyl)-5-isopropylphenyl)-1,2,4-oxadiazol-3-yl)-6-methylphenoxy)-2-hydroxypropyl)-2-hydroxyacetamide 
• 1187029-26-0 (S)-N-(3-(2-ethyl-4-(5-(3-((isobutyl(methyl)amino)methyl)-5-propylphenyl)-1,2,4-oxadiazol-3-yl)-6-methylphenoxy)-2-hydroxypropyl)-2-hydroxyacetamide 
• 1187028-58-5 N-((S)-3-{2-ethyl-4-[5-(3-formyl-5-isopropyl-phenyl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide 
• 1187028-57-4 N-((S)-3-{2-ethyl-4-[5-(3-formyl-5-propyl-phenyl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide 
• 1187028-56-3 N-((S)-3-{2-ethyl-4-[5-(3-formyl-5-ethyl-phenyl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide 
• 377734-27-5 methyl 3-bromo-5-formylbenzoate 

Relevant articles and documents

LOX ENZYME INHIBITING METHODS AND COMPOSITIONS

This invention relates to compounds, pharmaceutical compositions and their use for treating fibrotic disorders, proliferative disorders, cardiovascular diseases, acute and chronic inflammatory disorders, primary and metastatic cancer, pulmonary conditions, ocular diseases, or neurological and neuropsychiatric conditions. One particular aspect of the inventions relates to inhibitors of the family of lysyl oxidase enzymes and their use as therapeutics for fibrotic disorders.

A reactive nitrone-based organogel that self-assembles from its constituents in chloroform

The reversible reaction of an aldehyde with a hydroxylamine affords a nitrone which is capable of forming a stiff gel with chloroform at concentrations as low as 0.20 wt% (6 mM). The gelator forms dynamically from its constituents and the gel assembly can be degraded in a controlled manner through a recognition-mediated reaction that targets the nitrone component of the gel network.

NOVEL AMINOMETHYL BENZENE DERIVATIVES

The invention relates to novel aminomethyl benzene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. (I) wherein A represents one of the groups (I), (I), (I) and